TrialEuropean journal of heart failure2025

Long-term efficacy of tafamidis in patients with transthyretin amyloid cardiomyopathy by National Amyloidosis Centre stage.

Thibaud Damy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.